



NIPT is a potential emerging field in genetic prenatal diagnosis and screening. Thus, NIPT relies on the identification of
Down syndrome (DS) or trisomy 21 is the most common aneuploidy (1/800 live births) and the most common
cause of sever mental delay. DS is compatible with life but it involves some characteristic clinical features (Table
1). The high mortality is due to heart disease which is very frequent. In addition, maternal age and previous family













Scientific literature search on PubMed database: recent papers and reviews, chosen depending on their data of
publication and quality.
g
fetal genetic material in the blood of pregnant women without no additional risk of miscarriage. The presence of fetal
genetic material in the maternal bloodstream during the pregnancy is well‐known and it is explained by the
bidirectional traffic between the fetus and the mother through the placenta.
There are three possible fetal sources for NIPT (Figure 1): intact fetal cells, cell‐free fetal DNA (cffDNA) and cell‐free fetal
RNA (cffRNA). Moreover, clinical applications of NIPT can be classified in four groups: sex‐linked diseases, haemolytic
disease of the fetus and newborn (HDFN), monogenic diseases and chromosomal aneuploidies.
The detection of universal fetal markers minimizes the interference between maternal and fetal DNA in maternal
bloodstream. The different epigenetic pattern is an example of an useful method to detect fetal markers. In addition,
PLAC4 mRNA is a placental transcript located on chromosome 21 so it is interesting for Down syndrome (DS) testing.
Intact fetal cells
‐ Pregnancy specific









‐ Leukaemia susceptibility (at earlier ages)
Owing to its high incidence, DS is the main reason why women undergo prenatal testing. The detection of DS
prenatally involves screening and diagnostic testing. Currently, there are three screening algorithms designed
with the aim to estimate a pregnancy‐specific individual risk at carrying a DS fetus. These algorithms are based
on the evaluation of three elements: maternal age, nuchal translucency (NT) and maternal serum biomarkers.
Figure 6 only shows the first trimester combined test which is recommended by ISPD (International Society for
















‐Specific fetal markers are
necessary
1st trimester





expression levels in placenta



















Low risk Normal pregnancy control
Single counting molecular techniques
‐The main advantage: analysis of total DNA (fetal plus maternal)
‐ The main inconvenient: cost
on the screening results. A low risk
pregnancy involves a normal pregnancy
control with routine ecographies.
Nevertheless, a high risk pregnancy requires
to undergo a definitive diagnosis through








Technical steps (Figure 4):
1. Generation of millions of tags across the whole genome
2. Alignment and mapping of tags
3. Identification of chromosome origin







NIPT: screening or diagnosis?
Sensitivity and FPR are the variables that indicate if a test should be used for screening or diagnosis. NIPT
presents high sensitivity and low false positive rate (FPR) (Table 2). Currently, NIPT cannot be considered
diagnostic despite being a highly accurate screening test. Thus, invasive testing is also recommended in order to
confirm a positive NIPT result (Figure 8). Improving sensitivity and specificity is crucial to reduce the number of
invasive diagnostic tests offered to pregnant women and as a result reducing the number of miscarriages in










NIPT cannot be considered a diagnostic test
Two possible applications for NIPT:
‐ First‐line screening
‐ After a positive result from the current screening test
Advantages (comparing with Real‐time PCR)
‐ Standards are no necessary 
‐ Regulation of precision:
It depends on fetal DNA concentration
Application? Relative chromosome dosage (RCD)
Useful for Aneuploidy detection (Figure 3).
5. Comparison of the number of tags from each
chromosome to its reference value
Alternative approach:
Digital analysis of selected regions (DANSR)
Only it is analysed the chromosome of interest instead to
whole genome















Variable insurance coverage ? NIPT only afforded by
high‐income community
‐Genetic counseling difficulties
The development of NIPT has raised numerous ethical, social and legal issues so it is essential to evaluate the pros




implication ‐Unnecessary patient anxiety
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Figure 3. RCD scheme.2 Figure 4. MPS scheme.3
Figure 9. Summary of the pros and the cons of NIPT and their respective consequences.   
‐ NIPT is performed with the aim to identify fetal genetic material in maternal bloodstream so as to detect genetic
abnormalities. The absence of invasiveness allows to avoid additional risks caused by the procedure.
‐ NIPT can be applied for screening but not for definitive diagnosis.
‐ Economic, ethical, social and legal issues should be considered due to the ease and absence of risk performing NIPT.
